As of 2025-07-09, the EV/EBITDA ratio of Boya Bio-pharmaceutical Group Co Ltd (300294.SZ) is 33.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300294.SZ's latest enterprise value is 12,102.73 mil CNY. 300294.SZ's TTM EBITDA according to its financial statements is 359.03 mil CNY. Dividing these 2 quantities gives us the above 300294.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 29.4x | 26.4x |
| Forward P/E multiples | 11.1x - 15.5x | 12.4x |
| Fair Price | 14.89 - 23.07 | 18.69 |
| Upside | -43.0% - -11.7% | -28.5% |
| Date | EV/EBITDA |
| 2025-06-27 | 33.46 |
| 2025-06-26 | 33.40 |
| 2025-06-25 | 33.67 |
| 2025-06-24 | 33.53 |
| 2025-06-23 | 32.98 |
| 2025-06-20 | 32.94 |
| 2025-06-19 | 32.95 |
| 2025-06-18 | 33.22 |
| 2025-06-17 | 33.81 |
| 2025-06-16 | 34.13 |
| 2025-06-13 | 34.38 |
| 2025-06-12 | 35.09 |
| 2025-06-11 | 34.72 |
| 2025-06-10 | 35.07 |
| 2025-06-09 | 35.86 |
| 2025-06-06 | 35.52 |
| 2025-06-05 | 34.75 |
| 2025-06-04 | 35.06 |
| 2025-06-03 | 35.18 |
| 2025-05-30 | 34.65 |
| 2025-05-29 | 34.65 |
| 2025-05-28 | 34.10 |
| 2025-05-27 | 34.29 |
| 2025-05-26 | 34.24 |
| 2025-05-23 | 34.36 |
| 2025-05-22 | 34.52 |
| 2025-05-21 | 35.11 |
| 2025-05-20 | 34.97 |
| 2025-05-19 | 34.72 |
| 2025-05-16 | 34.78 |
| 2025-05-15 | 34.54 |
| 2025-05-14 | 34.85 |
| 2025-05-13 | 35.17 |
| 2025-05-12 | 34.78 |
| 2025-05-09 | 34.76 |
| 2025-05-08 | 34.93 |
| 2025-05-07 | 34.68 |
| 2025-05-06 | 34.69 |
| 2025-04-30 | 34.29 |
| 2025-04-29 | 34.36 |
| 2025-04-28 | 34.20 |
| 2025-04-25 | 34.80 |
| 2025-04-24 | 35.62 |
| 2025-04-23 | 35.66 |
| 2025-04-22 | 35.94 |
| 2025-04-21 | 35.87 |
| 2025-04-18 | 35.61 |
| 2025-04-17 | 36.62 |
| 2025-04-16 | 35.87 |
| 2025-04-15 | 37.00 |